2 New Dexcom G7 automated insulin delivery and smart insulin pen integrations also announced at ATTD reinforce the company’s status as the most connected CGM brand in the world. 3 During the ...

We are thrilled to extend a warm welcome to the 18th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2025), scheduled to take place from 19-22 March, 2025, in ...

Dexcom CGM builds on “most connected CGM brand” with new integrations announced at ATTD For more information about Dexcom presentations at ATTD and to register to virtually attend the ...

2 New Dexcom G7 automated insulin delivery and smart insulin pen integrations also announced at ATTD reinforce the company’s status as the most connected CGM brand in the world. 3 During the ...

The poster presentation at the ATTD conference will be titled "Early Feasibility Study to Evaluate an Intravascular Continuous Blood Glucose Monitor in Adults with Diabetes Mellitus." Glucotrack's ...

When will Glucotrack present its trial data? Glucotrack will present data from its first-in-human trial at the ATTD conference, held from March 19-22, 2025, in Amsterdam. What are the advantages ...

We look forward to sharing detailed findings from this important study at ATTD and advancing our clinical program with our upcoming chronic implant study.” Published first on TheFly – the ...

today announced the company will be attending The 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) Technology Fair in Amsterdam, Netherlands on March 19-22 ...

Organization Leverages Predictive Analytics and an Evidence-Based Peer Support Model to Expand Reach, Strengthen Engagement, and Improve Health Literacy Our participation at ATTD 2025 reflects our ...

Biomea’s presentations at ATTD 2025 will showcase preclinical data evaluating the combination of icovamenib with GLP-1 receptor agonists, as well as new clinical findings from the Expansion ...